Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,006.3
-10.9 (-0.36%)

 

  • STI Straits Times Index
    3,006.3
    -10.9 (-0.36%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,594.8
    -
    Index delayed 15 minutes
  • HSI Hang Seng Index
    29,927.8
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,621.3
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,646.4
    -110.4 (-0.38%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,413.9
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 2.2M
  • Value: 18.1M
  • Rise: -
  • Fall: -
  • Unch: 777

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.048+0.001
Artivision Tech0.011-
Penguin Intl0.650+0.020
AusGroup0.038-
Blumont0.005-
Lippo Malls Tr0.066-
V2Y Corp0.070+0.002
Sabana Reit0.385+0.010
Ascendas Reit3.130-
Mapletree Log Tr2.020-

World Indices

World Indices
Name Last Change
Nasdaq 13,530.9 +73.7
HSI 29,927.8
HSCEI 11,889.5
Jakarta 6,413.9
Nikkei 225 28,646.4 -110.4
SSE Comp 3,621.3
Shanghai A 3,795.9
Shanghai B 251.2
KOSPI 3,163.9 +3.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

AIM IMMUNOTECH INC AIM IMMUNOTECH
Updated on 20 Jan 2021 (End of trading day)
Last (USD): 2.210 Change: +0.110 High: 2.430 Remarks: -
Change (%): +5.24 Low: 2.090
Open 2.150 Yesterday's Close 2.1
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 9,204,080 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.23430 Trailing EPS (USD) e -0.28688 NAV (USD) b 1.4840
PE a - Trailing PE f - Price / NAV b 1.4892
Dividend (USD) d - Cash In Hand (USD) g 0.9462 Issued & Paid-up Shares c 40,686,500
Dividend Yield (%) d - Price / Cash In Hand g 2.336 Treasury Shares h -
Market Cap (M) 89.917 Enterprise Value (M) 53.358
Piotroski F Score 1 Exchange Code AIM Par Value ( $ ) n.a.
52 Weeks Volatility (%) 116.78 Free Float (%) 98.9
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Nov 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 03 Sep 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference AIM IMMUNOTECH INC NYSE American 89.917 - - 1.4892 -
Industry Biotechnology NYSE American 171.252 - - 4.4019 -
Local Peer ACTINIUM PHARMACEUTICALS INC NYSE American 667.375 - - 14.6909 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 449.973 - - 4.9302 -
Local Peer 22ND CENTURY GROUP INC NYSE American 262.038 - - 5.2372 -
Local Peer NANOVIRICIDES INC NYSE American 241.566 - - 8.0564 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 154.330 - - 2.0048 -
Local Peer MATINAS BIOPHARMA HOLDINGS INC NYSE American 147.155 - - 2.2906 -
Local Peer CEL-SCI CORP NYSE American 132.478 - - 6.7156 -
Local Peer IBIO INC NYSE American 134.588 - - 1.6812 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 106.509 - - -12.3403 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 63.025 - - 2.5600 -
Local Peer ORAGENICS INC NYSE American 55.187 - - 22.4000 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 46.469 - - 1.9692 -
Other Local Peers CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 146,916.169 18.735 19.983 13.4060 2.335
Global Peer CSL LTD ASX 122,287.912 38.991 38.991 12.8987 1.092
Global Peer GILEAD SCIENCES INC NASDAQ 85,227.505 15.824 67.214 4.8855 3.743
Global Peer VERTEX PHARMACEUTICAL NASDAQ 61,550.995 52.303 22.876 7.5676 -
Global Peer WUXI BIO HKEx 468,000.104 407.103 325.021 31.3296 -
Global Peer ILLUMINA INC NASDAQ 58,916.840 58.799 92.346 12.5355 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 57,863.446 27.348 18.334 5.7146 -
Global Peer MODERNA INC NASDAQ 49,519.149 - - 17.9430 -
Global Peer BIOGEN INC NASDAQ 41,591.227 7.063 8.183 3.8659 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 34,501.051 14.350 36.066 3.1152 -
Other Global Peers SEAGEN INC (NASDAQ), BEIGENE (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), SINO BIOPHARM (HKEx), 10X GENOMICS INC (NASDAQ), ZAI LAB-SB (HKEx), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), BIO-TECHNE CORP (NASDAQ), ABCELLERA BIOLOGICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), FATE THERAPEUTICS (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), NOVAVAX INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), TG THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), VIR BIOTECHNOLOGY INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ABCAM PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), SEER INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), Lonza (SGX), ALLOGENE THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), ARVINAS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), INSMED INC (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), VERACYTE INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ALLOVIR INC (NASDAQ), XENCOR INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), GENSCRIPT BIO (HKEx), SORRENTO THERAPEUTICS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), STOKE THERAPEUTICS INC (NASDAQ), 3SBIO (HKEx), SERES THERAPEUTICS (NASDAQ), KURA ONCOLOGY INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), VIVA BIOTECH (HKEx), MYRIAD GENETICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), SHATTUCK LABS INC (NASDAQ), JACOBIO-B (HKEx), PERSONALIS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), VIELA BIO INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), NANTKWEST INC (NASDAQ), REGENXBIO INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ALPHAMAB-B (HKEx), DICERNA PHARMACEUTICALS INC. (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), UNIQURE N.V. (NASDAQ), PRECIGEN INC (NASDAQ), NKARTA INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), JW THERAP-B (HKEx), BIOCRYST PHARMACEUTICALS INC (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), C4 THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), BIOATLA INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), GRACELL BIOTECHNOLOGIES INC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMMUNOGEN INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ALECTOR INC (NASDAQ), TRAVERE THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), FRONTAGE (HKEx), POLYNOVO LIMITED (ASX), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), MACROGENICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INHIBRX INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ASCENTAGE-B (HKEx), DYNE THERAPEUTICS INC (NASDAQ), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), VAXCYTE INC (NASDAQ), HAOHAI BIOTEC (HKEx), JHBP-B (HKEx), 4D MOLECULAR THERAPEUTICS INC (NASDAQ), EPIZYME INC (NASDAQ), PASSAGE BIO INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), SYNDAX PHARMACEUTICALS INC (NASDAQ), COMPUGEN (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), SIGILON THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), MIMEDX GROUP INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), HUMANIGEN INC (NASDAQ), CURIS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), ENANTA PHARMACEUTICALS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), CORTEXYME INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), KADMON HLDGS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AFFIMED N V (NASDAQ), COGENT BIOSCIENCES INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), VANDA PHARMACE INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), VAXART INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), FOGHORN THERAPEUTICS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), AGENUS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), SQZ BIOTECHNOLOGIES CO (NYSE), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), SINOMAB BIO-B (HKEx), ARDELYX INC (NASDAQ), AVROBIO INC (NASDAQ), ONCORUS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), AKOUOS INC (NASDAQ), KINTOR PHARMA-B (HKEx), SPECTRUM PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), FLEXION THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), ATRECA INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), CHIMERIX INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), GERON CORP (NASDAQ), OPTHEA LIMITED (ASX), PANDION THERAPEUTICS INC (NASDAQ), BIOVIE INC (NASDAQ), OPTHEA LIMITED SPON ADS EACH REPR 8 ORD SHS (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), SPRUCE BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), XBIOTECH INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), ASCLETIS-B (HKEx), SUMMIT THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XOMA CORP (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), LEE'S PHARM (HKEx), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), IMUGENE LIMITED (ASX), CYTOMX THERAPEUTICS INC (NASDAQ), VERASTEM INC (NASDAQ), ATHERSYS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), NEXTCURE INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), INMUNE BIO INC (NASDAQ), TREVENA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CABALETTA BIO INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), KAMADA LTD (NASDAQ), BELLUS HEALTH INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), ESSEX BIO-TECH (HKEx), ADICET BIO INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), IMMUNOPRECISE ANTIBODIES LTD (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), MEDICINOVA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), IMV INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), METACRINE INC (NASDAQ), OTONOMY INC (NASDAQ), CHIASMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), IMMUTEP LTD (ASX), EVOGENE LTD (NASDAQ), SESEN BIO INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), NEXT SCIENCE LTD (ASX), GENOCEA BIOSCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), ANTEOTECH LIMITED (ASX), BRAINSTROM CELL THERAPEUTICS (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AZIYO BIOLOGICS INC (NASDAQ), IMMUNOME INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), MINERVA NEUROSCIENCES INC (NASDAQ), SIO GENE THERAPIES INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), EQUILLIUM INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), SYNLOGIC INC (NASDAQ), ORGENESIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), GALECTIN THERAPEUTICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), CELYAD ONCOLOGY SPON ADS EACH REPR 1 ORD SHS (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), SAVARA INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), COHBAR INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), BIONOMICS LTD (ASX), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), UNI-BIO GROUP (HKEx), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), LEAF RESOURCES LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), RECRO PHARMA INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), BIOCARDIA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), ADVAXIS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), MEMPHASYS LTD (ASX), REGENT PACIFIC (HKEx), SUNESIS PHARMACEUTICALS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), VACCINEX INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), CLEVELAND BIOLABS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), KIROMIC BIOPHARMA INC (NASDAQ), SOLIGENIX INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), ALIMERA SCIENCES INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), CT ENTERPRISE (HKEx), ARCA BIOPHARMA INC (NASDAQ), BIOTRON (ASX), LIXTE BIOTECHNOLOGY HOLDINGS INC (NASDAQ), PRECIPIO INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), ATYR PHARMA INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), PATRYS LIMITED (ASX), CONSTELLATION TECHNOLOGIES LTD (ASX), AZURRX BIOPHARMA INC (NASDAQ), Suntar Eco-City (SGX), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), ADITX THERAPEUTICS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), INMED PHARMACEUTICALS INC (NASDAQ), HISTOGEN INC (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), REGENEUS LTD (ASX), ADALTA LTD (ASX), CYCLO THERAPEUTICS INC (NASDAQ), RHINOMED LIMITED (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AMPLIA THERAPEUTICS LTD (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), BIO-PATH HOLDINGS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), NANOLLOSE LTD (ASX), GEOVAX LABS INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CRYOSITE (ASX), HOLISTA COLLTECH LIMITED (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), SENESTECH INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.190
+9.41 %
10 Days -+0.140
+6.76 %
20 Days -+0.140
+6.76 %
Medium Term Return 3 Months -+0.130
+6.25 %
6 Months --0.860
-28.01 %
1 Year -+0.920
+71.32 %
Annualised Return Annualised --
+71.32 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.780 - 7.110 Change From 1 Year Low +1.430 % Change From 1 Year Low (%) +183.33
Change From 1 Year High -4.900 % Change From 1 Year High (%) -68.92
2 Years Range 0.381 - 7.110 Change From 2 Years Low +1.829 % Change From 2 Years Low (%) +480.05
Change From 2 Years High -4.900 % Change From 2 Years High (%) -68.92
5 Years Range 0.381 - 7.110 Change From 5 Years Low +1.829 % Change From 5 Years Low (%) +480.05
Change From 5 Years High -4.900 % Change From 5 Years High (%) -68.92
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.

Historical Price Data

Date Open High Low Close Volume VWAP
20 Jan 2021 2.150 2.430 2.090 2.210 9,204,080 -
19 Jan 2021 2.080 2.110 2.030 2.100 1,502,691 -
15 Jan 2021 2.000 2.080 1.970 2.040 1,381,033 -
14 Jan 2021 2.060 2.070 2.010 2.020 955,288 -
13 Jan 2021 2.050 2.090 2.025 2.040 989,740 -
12 Jan 2021 2.080 2.080 1.990 2.050 920,623 -
11 Jan 2021 2.050 2.100 2.000 2.070 1,788,350 -
08 Jan 2021 2.060 2.080 1.990 2.070 1,680,786 -
07 Jan 2021 1.950 2.080 1.910 2.070 2,082,711 -
06 Jan 2021 1.950 1.990 1.850 1.880 1,823,935 -
05 Jan 2021 1.880 1.930 1.860 1.930 881,099 -
04 Jan 2021 1.790 1.930 1.760 1.910 1,253,108 -
31 Dec 2020 1.850 1.880 1.750 1.790 1,712,324 -
30 Dec 2020 1.870 1.900 1.830 1.870 1,250,418 -
29 Dec 2020 1.980 1.990 1.850 1.870 2,385,960 -
28 Dec 2020 2.160 2.160 1.980 2.010 2,125,620 -
24 Dec 2020 2.150 2.200 2.020 2.070 5,251,790 -
23 Dec 2020 2.020 2.030 1.950 1.970 2,215,915 -
22 Dec 2020 2.160 2.180 1.970 2.060 5,191,731 -
21 Dec 2020 2.400 2.400 2.040 2.180 35,501,480 -
18 Dec 2020 1.950 2.020 1.910 1.910 2,527,719 -
17 Dec 2020 1.770 1.930 1.745 1.870 2,772,835 -
Summary
Current 2 Weeks
(06 Jan 2021 to 20 Jan 2021)
1.950 2.430 1.850 2.210 22,329,237 -
Previous 2 Weeks
(21 Dec 2020 to 05 Jan 2021)
2.400 2.430 1.850 1.930 57,769,445 -
4 Weeks from
(20 Nov 2020 to 18 Dec 2020)
1.930 2.430 1.850 1.910 25,907,143 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.